New device at Western Eye hospital is helping minimise treatments needed to prevent eyesight loss in glaucoma patients
Surgeons at Western Eye hospital, part of Imperial College Healthcare NHS Trust, are among the first in the UK to introduce a brand new surgical device that minimises the range and amount of treatment required to prevent sight loss in glaucoma patients.
Initial results from the first 40 patients who received the Cypass device at the Western Eye Hospital between June 2017 and November 2017 have already seen a 30 per cent drop in eye pressure and an 80 per cent reduction in glaucoma drops, from an average of 2.5 drops to 0.5.
The new Cypass stent is a new device that is implanted into the eye to lower eye pressure. The device is a very small tube and measures just 6.3 mm in length and 0.5 mm wide. Current treatment involves lowering eye pressure with a combination of eye drops, laser and surgery.
The implant can be used in patients with mild to moderate glaucoma who need to have cataract surgery to improve their vision. The device is implanted into the eye and allows the fluid within the eyeball to drain out more effectively, eventually reducing the need for glaucoma medications and significantly reduce eye pressure.
Mr Faisal Ahmed, consultant ophthalmic surgeon, said: “This is an exciting new device that shows great promise in being able to reduce eye pressure and potentially allows patients to come off their glaucoma medications.
“The initial results are extremely promising and we will continue to measure how beneficial this could be for patients and preventing eyesight loss.”
Consultant ophthalmic surgeons and glaucoma specialists at the Western Eye Hospital, Mr Faisal Ahmed, Ms Sally Ameen, Professor Philip Bloom, Ms Laura Crawley Mr Eduardo Normando and Professor Francesca Cordeiro have now operated on over 100 patients so far.